18 February 2024
Prof. Dr. Lukasz Kurgan and Prof. Dr. Peter E. Nielsen Appointed Editors-in-Chief of Biomolecules
We are pleased to announce that Prof. Dr. Lukasz Kurgan and Prof. Dr. Peter E. Nielsen have been appointed Editors-in-Chief of Biomolecules (ISSN: 2218-273X).
Biomolecules lies at the intersection between chemistry, biology, molecular medicine, and material science. We publish studies that involve basic research, in vitro and in vivo investigations, and pre-clinical studies that focus on the structures and functions of bioactive and biogenic substances, molecular mechanisms with biological and medical implications, and biomaterials and their applications.
Prof. Dr. Kurgan’s research is at the intersection of bioinformatics, protein science, and machine learning, focusing on the development of modern tools and resources for the high-throughput prediction and characterization of the function, structure, and intrinsic disorder of proteins. He has published well over 200 peer-reviewed articles, around 30 book chapters, and 2 books. Prof. Dr. Kurgan was elected a Fellow of the Royal Society of Biology (2023), a Member of the European Academy of Sciences and Arts (2022), and a Fellow of the American Institute for Medical and Biological Engineering (2021); he is also a Member of the Faculty Opinions in the field of bioinformatics, biomedical informatics and computational biology. He has been involved with Biomolecules since 2018, recently serving as the Section Editor-in-Chief for the “Bioinformatics and Systems Biology” Section. He is also deeply grateful to the outgoing Editor-in-Chief, Prof. Dr. Uversky, for his many years of leadership that have grown the reputation and reach of Biomolecules. He hopes to further strengthen the position of Biomolecules so that it becomes a preferred destination for high-impact research on biomolecules and bioactive and biogenic compounds.
Prof. Dr. Peter E. Nielsen has been affiliated with the University of Copenhagen since 1980, where he became a full professor in 1995. He is one of the inventors of peptide nucleic acid (PNA) (1991) and has further studied and developed this DNA mimic over the last 30 years in relation to chemistry, molecular biology, and drug discovery. Presently, his research is centered around the delivery and bioavailability of PNA and other potential gene therapeutic drugs with a strong focus on novel antimicrobial agents.
Prof. Dr. Peter E. Nielsen is the co-author of more than 400 scientific papers, reviews, and book chapters (with over 17000 citations). In addition to holding over 20 patents and patent applications, he is the editor of six books, and he serves on the advisory board of several scientific journals. He holds an M.Sc. in biochemistry, a Ph.D. in chemistry, and an honorary doctoral degree, all from the University of Copenhagen. He is the co-founder of two biotech companies in Denmark. He is a member of the EMBO (the European Molecular Biology Organization) and the Danish Academy of Technical Sciences (ATV), and he has received several national and international scientific prizes.
His aim is to make Biomolecules an even more attractive scientific journal that publishes high-quality, high-impact scientific papers on biologically relevant molecules for the benefit of global science. He recognizes that this is a self-reinforcing process.
As we welcome our new Editors-in-Chief, we express our gratitude to the outgoing Editor-in-Chief, Prof. Dr. Vladimir Uversky, for his dedication and continuing support of Biomolecules. We are confident that Prof. Dr. Lukasz Kurgan and Prof. Dr. Peter E. Nielsen will continue to offer invaluable input and support and will maintain the high standards of qualitative scientific communications in Biomolecules.
We warmly welcome Prof. Dr. Lukasz Kurgan and Prof. Dr. Peter E. Nielsen as our Editors-in-Chief and look forward to their collaboration and input for the continued success of Biomolecules.
